Document Detail

A comparison of oxitropium bromide and ipratropium bromide in asthma.
MedLine Citation:
PMID:  6230249     Owner:  NLM     Status:  MEDLINE    
Oxitropium bromide is a derivative of scopolamine and is an anticholinergic drug. Twenty asthmatics completed the study in which they received, in randomised double-blind fashion, placebo, ipratropium bromide 80 micrograms, and oxitropium bromide 200 micrograms. The patients recorded peak expiratory flow immediately before inhalation and up to 10 h afterwards. PEF were significantly higher than placebo between 10 min and 10 h, for both active treatments. There were no significant differences between values on oxitropium bromide and ipratropium bromide at any time points. Side effects were minimal and oxitropium bromide is an effective bronchodilator in asthma.
E T Peel; G Anderson; B Cheong; N Broderick
Related Documents :
2719659 - The interplay of electrostatic fields and binding interactions determining catalytic-si...
14756259 - Equilibria occurring between beryllium (ii) and salicylate ions.
16538269 - The direct determination of partial molar volumes and reaction volumes in ultra-dilute ...
23769 - The ph-dependence of second-order rate constants of enzyme modification may provide fre...
24427059 - A second monoclinic polymorph of 3,5-di-tert-butyl-2-hy-droxy-benzaldehyde.
16527529 - The surfactant sensitized analytical reaction of cerium(iv) with some triphenylformazan...
21202619 - Redetermination of 3-deaza-uracil.
24671689 - Expression, purification, and crystallization of hsv-1 glycoproteins for structure dete...
18939629 - Iron acquisition by ornithobacterium rhinotracheale.
Publication Detail:
Type:  Clinical Trial; Comparative Study; Journal Article    
Journal Detail:
Title:  European journal of respiratory diseases     Volume:  65     ISSN:  0106-4339     ISO Abbreviation:  Eur J Respir Dis     Publication Date:  1984 Feb 
Date Detail:
Created Date:  1984-04-12     Completed Date:  1984-04-12     Revised Date:  2007-11-15    
Medline Journal Info:
Nlm Unique ID:  8006891     Medline TA:  Eur J Respir Dis     Country:  DENMARK    
Other Details:
Languages:  eng     Pagination:  106-8     Citation Subset:  IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Asthma / drug therapy*,  physiopathology
Atropine Derivatives / therapeutic use*
Clinical Trials as Topic
Double-Blind Method
Ipratropium / administration & dosage,  therapeutic use*
Middle Aged
Peak Expiratory Flow Rate
Random Allocation
Scopolamine Derivatives / administration & dosage,  therapeutic use*
Time Factors
Reg. No./Substance:
0/Aerosols; 0/Atropine Derivatives; 0/Scopolamine Derivatives; 30286-75-0/oxitropium; 60205-81-4/Ipratropium

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Inhibitory effects of a synthetic pentapeptide on hemopoietic stem cells in vitro and in vivo.
Next Document:  Factors determining residual volume in normal and asthmatic subjects.